Alexion, Pharmacyclics Buck Trend in Biotech Short Interest (ALXN, CELG, PCYC)

By: Benzinga
Declining short interest in Alexion Pharmaceuticals (NASDAQ: ALXN ) and Pharmacyclics (NASDAQ: PCYC ) bucked the trend among leading biotech and emerging pharmaceutical companies between the August 15 and August 30 settlement dates. The number of shares sold short in Amgen (NASDAQ: AMGN ), Biogen Idec (NASDAQ:
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.